Myelodysplastic syndromes trials in Greece
7 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Lower Risk Myelodysplastic Syndromes (LR-MDS) Who Need Regular Blood Transfusions
- Where
- Alexandroupoli, Athens, Chaïdári, Ioannina, Thessaloniki
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- Takeda
See details and how to joinNCT07422480 · EU 2025-523544-12-00 - Phase 1Enrolling by invitationA Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
- Where
- Athens
- Age
- 18 years and over
- People
- 120 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06788509 · EU 2024-515457-21-00 - No phaseTaking peopleEarly Detection and Screening of Hematological Malignancies - SANGUINE
- Where
- Athens
- Age
- 18 years and over
- People
- 3,000 worldwide
- Run by
- JaxBio Ltd
See details and how to joinNCT05735704 - Phase 3Taking peopleLisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).
- Where
- Alexandroupoli, Athens, Chaïdári, Patra, Thessaloniki
- Age
- 18 years and over
- People
- 490 worldwide
- Run by
- Ascentage Pharma Group Inc.
See details and how to joinNCT06641414 · EU 2024-517247-31-00 - Phase 3Taking peopleA Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
- Where
- Athens, Rio Patras, Thessaloniki
- Age
- 18 years and over
- People
- 665 worldwide
- Run by
- Celgene
See details and how to joinNCT04064060 - Phase 1/2Taking peopleAB8939 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
- Where
- athens, Athens, Patra
- Age
- 18 years and over
- People
- 78 worldwide
- Run by
- AB Science
See details and how to joinNCT05211570 · EU 2024-516641-39-00 - Phase 2Taking peopleA Trial Testing SP-420 in Subjects With Transfusion-dependent β-thalassemia or Low-risk Myelodysplastic Syndromes
- Where
- Athens, Chaïdári, Ioannina, Larissa, Patra, Thessaloniki
- Age
- 18 years to 64 years
- People
- 90 worldwide
- Run by
- Pharmacosmos A/S
See details and how to joinNCT05693909 · EU 2023-507396-21-00